How to buy AFT Pharmaceuticals shares

AFT Pharmaceuticals Limited is a drug manufacturers—specialty & generic business based in Australia. AFT Pharmaceuticals shares (AFP) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. and has a market cap (total outstanding shares value) of $492 million.

How to buy shares in AFT Pharmaceuticals

1. Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
3. Search for AFT Pharmaceuticals. Find the share by name or ticker symbol: AFP. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until AFT Pharmaceuticals reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At today's price of $N/A, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
6. Check in on your investment. Congratulations, you own a part of AFT Pharmaceuticals. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

AFT Pharmaceuticals share price

Use our graph to track the performance of AFP stocks over time.

AFT Pharmaceuticals shares at a glance

• Key figures

Information last updated 2020-09-25.

52-week range	AUDA$2.66 - AUDA$5.05
50-day moving average	AUDA$4.6169
200-day moving average	AUDA$4.088
Target price	N/A
PE ratio	39.1245
Dividend yield	N/A (0%)
Earnings per share (TTM)	AUDA$0.1175

Share Trading Account Offer

IG Share Trading Offer

AUD 8

Standard brokerage - Australian shares

Share Trading Account Offer

Competitive broker fees on Australian and international shares

• Brokerage - AU shares: From AUD 5 or 0.05%
• Brokerage - US shares: USD 0
• Sign-up process: Instant
• Support - After hours: Yes

Go to site

More info

Important: Share trading carries risk of capital loss.

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.

Is it a good time to buy AFT Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of AFT Pharmaceuticals Limited by TradingView

Is AFT Pharmaceuticals under- or over-valued?

Valuing AFT Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of AFT Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

AFT Pharmaceuticals's P/E ratio

AFT Pharmaceuticals's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 39x. In other words, AFT Pharmaceuticals shares trade at around 39x recent earnings.

That's relatively high compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

AFT Pharmaceuticals financials

Gross profit TTM	$48.3 million
Return on assets TTM	9.54%
Return on equity TTM	113.6%
Profit margin	12.02%
Book value	N/A
Market capitalisation	$492 million

TTM: trailing 12 months

AFT Pharmaceuticals share dividends

We're not expecting AFT Pharmaceuticals to pay a dividend over the next 12 months.

AFT Pharmaceuticals share price volatility

Over the last 12 months, AFT Pharmaceuticals's shares have ranged in value from as little as $2.66 up to $5.05. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while AFT Pharmaceuticals's is 0.3888. This would suggest that AFT Pharmaceuticals's shares are less volatile than average (for this exchange).

AFT Pharmaceuticals overview

AFT Pharmaceuticals Limited develops, licenses, and sells pharmaceutical products in New Zealand, Australia, Southeast Asia, and internationally. The company offers approximately 130 prescription and non-prescription products for use in the areas of allergy, eye care, first aid, fungal, pain management, and skin care, as well as supplements. It is also involved in the distribution of pharmaceuticals. The company was founded in 1997 and is headquartered in Auckland, New Zealand.

Frequently asked questions

• What percentage of AFT Pharmaceuticals is owned by insiders or institutions?

  Currently 76.093% of AFT Pharmaceuticals shares are held by insiders and 13.363% by institutions.

• When does the fiscal year end for AFT Pharmaceuticals?

  AFT Pharmaceuticals's fiscal year ends in March.

• Where is AFT Pharmaceuticals based?

  AFT Pharmaceuticals's address is: 129 Hurstmere Road, Auckland, New Zealand, 0622